Viking Global Investors is a Connecticut-based hedge fund specializing in venture capital investments across various stages. The firm demonstrates a diverse investment approach, participating in funding rounds from seed to late-stage, with a particular focus on Series A to Series E rounds. Viking Global Investors typically invests in innovative companies across multiple sectors, including biotechnology, healthcare, technology, and consumer goods.
Notable portfolio companies include Moderna, Ginkgo Bioworks, Impossible Foods, and Roivant Sciences. Viking Global Investors has supported numerous high-profile startups that have gone on to achieve significant success and valuations. The firm's investment strategy appears to prioritize companies with disruptive technologies and potential for substantial growth, particularly in the life sciences and technology sectors.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.